- Home
- Equipment
- north america
- neuroendocrine tumor
Refine by
Neuroendocrine Tumor Equipment Supplied In North America
11 equipment items found
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
LUTATHERA is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors in ...
Manufactured by:Ampersand Biosciences based inLake Clear, NEW YORK (USA)
Chromogranin B (CgB) aka Secretogranin-1, Uniprot # P05060, is an acidic member of the granin family found in a variety of neurons and endocrine cells. CgB is a marker in neuroendocrine tumors with plasma levels potentially being associated with disease ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
NETSPOT, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. ...
Manufactured by:Ampersand Biosciences based inLake Clear, NEW YORK (USA)
Chromogranin A (CgA), UniProt # P10645, is a 439 amino acid member of the granin family of secretory proteins. Found in vesicles of neuroendocrine cells, CgA is considered a valuable marker for neuroendocrine tumors. CgA is a precursor to a number of biologically active peptides including vasostatin I, parastatin, and ...
Manufactured by:SOFIE based inDulles, VIRGINIA (USA)
NETSPOT, after radiolabeling with Ga 68, is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
ClearView Vial Shield can be used for Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan or 177Lu-PSMA-617) for the treatment of prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer (PSMA-positive ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
The ClearView Rolling Shield is a mobile rolling shield available in lead equivalency up to 1’’ Pb.Eq. and is being used in several Theranostics suites and radiotherapies such as Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan ...
Manufactured by:Radium Incorporated based inWaynesboro, VIRGINIA (USA)
The ClearView Infusion Pump Shield works for infusion treatments from Ac-225 PSMA, I-123 and I-131 mIBG therapies, Lutathera (Lu-177) therapies for Neuroendocrine Tumor Treatment, FDA approved PluvictoTM (lutetium Lu 177 vipivotide tetraxetan or 177Lu-PSMA-617) for the treatment of prostate-specific membrane antigen–positive metastatic castration-resistant ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
This medicinal product is for diagnostic use only. After radiolabelling with gallium (68Ga) chloride solution, the solution of gallium (68Ga) edotreotide obtained is indicated for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NET) for localising ...
Manufactured by:SOFIE based inDulles, VIRGINIA (USA)
Neuraceq is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Toripalimab is the first domestic anti-tumor PD-1 antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract ...